Lockheed Martin Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Buy
14,590
+2,510
+21% +$2.54M 0.49% 43
2025
Q4
$13M Buy
12,080
+310
+3% +$296K 0.43% 41
2025
Q3
$8.98M Sell
11,770
-27,400
-70% -$20.4M 0.33% 60
2025
Q2
$30.5M Buy
39,170
+19,800
+102% +$15.4M 1.12% 24
2025
Q1
$16M Sell
19,370
-3,920
-17% -$3.26M 0.65% 39
2024
Q4
$18M Buy
23,290
+6,510
+39% +$5.39M 0.72% 35
2024
Q3
$14.9M Buy
16,780
+14,280
+571% +$12.8M 0.69% 34
2024
Q2
$2.26M Buy
+2,500
New +$2M 0.13% 76

Other funds holding LLY

Lockheed Martin Investment Management's LLY Position: Q1 2026 in Review

Lockheed Martin Investment Management increased its Eli Lilly (LLY) stake by 21% in Q1 2026, buying an estimated $2.54M and bringing the position to 14,590 shares worth $13.4M. The position accounts for 0.49% of the portfolio, ranked #43.

Lockheed Martin Investment Management first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $30.5M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lockheed Martin Investment Management held 14,590 shares of Eli Lilly worth $13.4M as of Q1 2026.
  • Lockheed Martin Investment Management bought 2,510 Eli Lilly shares in Q1 2026, an estimated $2.54M.
  • Eli Lilly made up 0.49% of Lockheed Martin Investment Management's portfolio in Q1 2026, its #43 holding.
  • Lockheed Martin Investment Management first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Lockheed Martin Investment Management's Eli Lilly position peaked at $30.5M in Q2 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lockheed Martin Investment Management's 13F filing for Q1 2026, filed 7 May 2026.